[Localized 31 phosphorus NMR spectroscopy of the human heart--development of a measuring method and initial clinical application].
In this work, the technique of 31P-NMR-spectroscopy is applied for the first time to diagnose coronary heart disease in patients, using a suitable measuring technique. In 13 healthy volunteers we applied a method comfortable and tolerable for patients, which enabled us to examine the myocardium inside the reception area of a surface coil. Concerning myocardium-specific selectivity and sensitivity the localization techniques FROGS (Fast-ROtating-Gradient-Spectroscopy), 1-D-ISIS (1-Dimensional-Image-Selected-In-vivo-Spectroscopy) and 3-D-ISIS were compared. By a combination of the 3-D-ISIS-technique with magnetic resonance imaging, we obtained a monitored position of the volume of interest (VOI) within the myocardium, thus gaining a selective measurement. The cube-shaped VOI with a lateral length of 50 mm was placed into the apical-septal area of the myocardium. On the basis of the obtained results, we examined seven patients suffering from coronary heart disease, which was symptomatic and verified by coronary angiography. The 31P-NMR-spectra of the two examined groups were computed into numbers representing the relative content of the myocardial high-energy-phosphates. In addition, the quotients PCr/ATP and Pi/ATP were calculated and compared. With this small number of cases the evaluation of the PCr/ATP-ratios already showed a significant difference of 0.34 (p less than 0.01) between patients with coronary heart disease (0.49 +/- 0.19) and healthy volunteers (0.83 +/- 0.27). The findings suggest the conclusion that 31P-NMR-spectroscopy is able to be instrumental in the diagnostic detection assessment of the metabolic state in coronary heart disease.(ABSTRACT TRUNCATED AT 250 WORDS)
Friedrich
M
M
Medizinische Klinik II mit Poliklinik, Universität Erlangen-Nürnberg, Siemens AG, Erlangen.
Weikl
A
A
Sauter
R
R
Reinhardt
E R
ER
Bachmann
K
K
D000255:Adenosine Triphosphate / Q000378:metabolism; D003327:Coronary Disease / Q000175:diagnosis* / Q000503:physiopathology; D004562:Electrocardiography / Q000295:instrumentation; D004734:Energy Metabolism / Q000502:physiology*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000295:instrumentation*; D009682:Magnetic Resonance Spectroscopy / Q000295:instrumentation*; D009206:Myocardium / Q000378:metabolism*; D010101:Oxygen Consumption / Q000502:physiology; D010710:Phosphates / Q000378:metabolism*; D010725:Phosphocreatine / Q000378:metabolism; D012016:Reference Values; D012815:Signal Processing, Computer-Assisted / Q000295:instrumentation
D010710:Phosphates; D010725:Phosphocreatine; D000255:Adenosine Triphosphate
Lokalisierte 31Phosphor-NMR-Spektroskopie des menschlichen Herzens--Entwicklung einer Messmethode und erste klinische Applikation.